A nutrition research group at a European university was validating an in vitro lipid digestion model for the second time in a year. Their first validation round had produced inconsistent results — simulated gastric lipase activity looked plausible, but the pancreatic phase was generating hydrolysis rates that were 30 to 40 percent below published values from three reference studies. They had rechecked their enzyme concentrations, their bile salt concentrations, their pH settings. Everything matched the protocol. The problem, they eventually traced to a shelf in their reagent room, was the triolein they were using as substrate. The bottle was labeled 99% purity. The actual content of the triglyceride they needed — glyceryl trioleate with all three oleic acid chains in the cis-9 configuration — was considerably lower, because the oleic acid component in their reagent contained a significant proportion of elaidic acid, the trans isomer, which is not metabolized identically by pancreatic lipase.